Celldex Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
Celldex Therapeutics, Inc. (CLDX) reported Increase (Decrease) in Other Operating Liabilities of -$1.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$490.00K.
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$1.36M.
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $1.38M.
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$410.00K.
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was -$753.00K.
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was -$5.64M, a 1319.91% decline from fiscal 2023.
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was $462.00K, a 83.05% decline from fiscal 2022.
- Celldex Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $2.73M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.85M 10-Q · filed 2026-08-06 | -$467.00K derived: sum of 3 quarters · filed 2026-08-06 | -$877.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.36M 10-Q · filed 2026-05-07 | $23.00K derived: sum of 2 quarters · filed 2026-05-07 | -$387.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $971.00K derived: sum of 2 quarters · filed 2026-02-25 | -$149.00K derived: sum of 3 quarters · filed 2026-08-06 | -$753.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | -$410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.53M derived: sum of 2 quarters · filed 2026-08-06 | -$2.13M 10-Q · filed 2025-11-10 | -$2.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.72M 10-Q · filed 2026-08-06 | -$2.57M derived: sum of 3 quarters · filed 2026-08-06 | -$5.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$604.00K 10-Q · filed 2026-05-07 | -$1.45M derived: sum of 2 quarters · filed 2026-05-07 | -$4.14M derived: sum of 3 quarters · filed 2026-05-07 | -$4.77M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$3.54M derived: sum of 2 quarters · filed 2026-02-25 | -$4.17M derived: sum of 3 quarters · filed 2026-02-25 | -$5.64M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.32M derived: sum of 2 quarters · filed 2025-11-10 | -$4.79M 10-Q · filed 2025-11-10 | -$5.46M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$632.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$2.10M 10-Q · filed 2025-08-07 | -$2.76M derived: sum of 3 quarters · filed 2026-02-25 | $81.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$1.47M 10-Q · filed 2025-05-08 | -$2.13M derived: sum of 2 quarters · filed 2026-02-25 | $713.00K derived: sum of 3 quarters · filed 2026-02-25 | $318.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.18M derived: sum of 2 quarters · filed 2026-02-25 | $1.79M derived: sum of 3 quarters · filed 2026-02-25 | $462.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.45M derived: sum of 2 quarters · filed 2024-11-06 | $1.13M 10-Q · filed 2024-11-06 | $589.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$395.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.72M 10-Q · filed 2024-08-08 | -$2.26M derived: sum of 3 quarters · filed 2025-02-27 | -$2.88M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.32M 10-Q · filed 2024-05-06 | -$1.86M derived: sum of 2 quarters · filed 2025-02-27 | -$2.48M derived: sum of 3 quarters · filed 2025-02-27 | -$2.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.16M derived: sum of 2 quarters · filed 2025-02-27 | -$1.55M derived: sum of 3 quarters · filed 2025-02-27 | $2.73M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$624.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.01M derived: sum of 2 quarters · filed 2023-11-02 | $3.26M 10-Q · filed 2023-11-02 | $2.71M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$387.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.89M 10-Q · filed 2023-08-08 | $3.34M derived: sum of 3 quarters · filed 2024-02-26 | $3.46M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $4.27M 10-Q · filed 2023-05-04 | $3.72M derived: sum of 2 quarters · filed 2024-02-26 | $3.85M derived: sum of 3 quarters · filed 2024-02-26 | $446.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$423.00K derived: sum of 2 quarters · filed 2024-02-26 | -$3.83M derived: sum of 3 quarters · filed 2024-02-26 | -$4.41M 10-K · filed 2024-02-26 |
| 2021-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.28M derived: sum of 2 quarters · filed 2022-11-09 | -$3.85M 10-Q · filed 2022-11-09 | -$3.18M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$3.98M 10-Q · filed 2022-08-08 | -$3.31M derived: sum of 3 quarters · filed 2023-02-28 | -$3.39M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$578.00K 10-Q · filed 2022-05-05 | $97.00K derived: sum of 2 quarters · filed 2023-02-28 | $18.00K derived: sum of 3 quarters · filed 2023-02-28 | -$626.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $596.00K derived: sum of 2 quarters · filed 2023-02-28 | -$48.00K derived: sum of 3 quarters · filed 2023-02-28 | -$816.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$723.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.49M 10-Q · filed 2021-11-09 | -$4.55M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$1.41M 10-Q · filed 2021-08-05 | -$4.48M derived: sum of 3 quarters · filed 2022-02-28 | -$5.18M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$768.00K 10-Q · filed 2021-05-06 | -$3.83M derived: sum of 2 quarters · filed 2022-02-28 | -$4.53M derived: sum of 3 quarters · filed 2022-02-28 | -$5.63M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$3.77M derived: sum of 2 quarters · filed 2022-02-28 | -$4.86M derived: sum of 3 quarters · filed 2022-02-28 | -$6.60M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$702.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.80M derived: sum of 2 quarters · filed 2020-11-05 | -$3.54M 10-Q · filed 2020-11-05 | -$6.44M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$2.83M 10-Q · filed 2020-08-06 | -$5.74M derived: sum of 3 quarters · filed 2021-03-29 | -$5.70M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | -$1.74M 10-Q · filed 2020-05-06 | -$4.64M derived: sum of 2 quarters · filed 2021-03-29 | -$4.61M derived: sum of 3 quarters · filed 2021-03-29 | -$3.93M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$2.87M derived: sum of 2 quarters · filed 2021-03-29 | -$2.19M derived: sum of 3 quarters · filed 2021-03-29 | -$3.27M 10-K · filed 2021-03-29 |
| 2018-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $709.00K derived: sum of 2 quarters · filed 2019-11-12 | -$366.00K 10-Q · filed 2019-11-12 | -$3.74M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $678.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$397.00K 10-Q · filed 2019-08-07 | -$3.77M derived: sum of 3 quarters · filed 2020-03-26 | -$4.19M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | -$1.07M 10-Q · filed 2019-05-07 | -$4.45M derived: sum of 2 quarters · filed 2020-03-26 | -$4.87M derived: sum of 3 quarters · filed 2020-03-26 | -$4.64M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$3.80M derived: sum of 2 quarters · filed 2020-03-26 | -$3.56M derived: sum of 3 quarters · filed 2020-03-26 | -$4.36M 10-K · filed 2020-03-26 |
| 2017-09-30 | -$421.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$185.00K derived: sum of 2 quarters · filed 2018-11-07 | -$987.00K 10-Q · filed 2018-11-07 | -$1.94M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$566.00K 10-Q · filed 2018-08-08 | -$1.52M derived: sum of 3 quarters · filed 2019-03-07 | -$1.77M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$802.00K 10-Q · filed 2018-05-10 | -$1.75M derived: sum of 2 quarters · filed 2019-03-07 | -$2.01M derived: sum of 3 quarters · filed 2019-03-07 | -$1.98M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$1.20M derived: sum of 2 quarters · filed 2019-03-07 | -$1.18M derived: sum of 3 quarters · filed 2019-03-07 | -$2.01M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$228.00K derived: sum of 2 quarters · filed 2017-11-07 | -$1.05M 10-Q · filed 2017-11-07 | $7.44M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$803.00K 10-Q · filed 2017-08-08 | $7.69M derived: sum of 3 quarters · filed 2018-03-07 | $7.41M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | -$826.00K 10-Q · filed 2017-05-09 | $7.67M derived: sum of 2 quarters · filed 2018-03-07 | $7.39M derived: sum of 3 quarters · filed 2018-03-07 | $7.17M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $8.22M derived: sum of 2 quarters · filed 2018-03-07 | $8.00M derived: sum of 3 quarters · filed 2018-03-07 | $7.20M 10-K · filed 2018-03-07 |
| 2015-09-30 | -$275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$492.00K derived: sum of 2 quarters · filed 2016-11-07 | -$1.29M 10-Q · filed 2016-11-07 | $295.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$1.01M 10-Q · filed 2016-08-08 | $570.00K derived: sum of 3 quarters · filed 2017-03-14 | $247.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$798.00K 10-Q · filed 2016-05-05 | $787.00K derived: sum of 2 quarters · filed 2017-03-14 | $464.00K derived: sum of 3 quarters · filed 2017-03-14 | $5.18M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $1.26M derived: sum of 2 quarters · filed 2017-03-14 | $5.98M derived: sum of 3 quarters · filed 2017-03-14 | $6.58M 10-K · filed 2017-03-14 |
| 2014-09-30 | -$323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $4.40M derived: sum of 2 quarters · filed 2015-11-05 | $4.99M 10-Q · filed 2015-11-05 | $4.88M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $5.32M 10-Q · filed 2015-08-10 | $5.20M derived: sum of 3 quarters · filed 2016-02-25 | $6.47M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $595.00K 10-Q · filed 2015-04-29 | $480.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.75M derived: sum of 3 quarters · filed 2016-02-25 | $1.40M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$115.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $1.16M derived: sum of 2 quarters · filed 2016-02-25 | $801.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.32M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $916.00K derived: sum of 2 quarters · filed 2014-11-05 | $1.43M 10-Q · filed 2014-11-05 | $1.41M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $162.00K 10-Q · filed 2014-08-07 | $136.00K derived: sum of 3 quarters · filed 2015-02-24 | $183.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $516.00K 10-Q · filed 2014-05-01 | $490.00K derived: sum of 2 quarters · filed 2015-02-24 | $537.00K derived: sum of 3 quarters · filed 2015-02-24 | $504.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $21.00K derived: sum of 2 quarters · filed 2015-02-24 | -$12.00K derived: sum of 3 quarters · filed 2015-02-24 | $594.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $14.00K derived: sum of 2 quarters · filed 2013-11-08 | $620.00K 10-Q · filed 2013-11-08 | $574.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $573.00K 10-Q · filed 2013-08-06 | $527.00K derived: sum of 3 quarters · filed 2014-03-03 | $313.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $606.00K 10-Q · filed 2013-05-03 | $560.00K derived: sum of 2 quarters · filed 2014-03-03 | $346.00K derived: sum of 3 quarters · filed 2014-03-03 | $180.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$260.00K derived: sum of 2 quarters · filed 2014-03-03 | -$426.00K derived: sum of 3 quarters · filed 2014-03-03 | -$138.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | -$214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$380.00K derived: sum of 2 quarters · filed 2012-11-02 | -$92.00K 10-Q · filed 2012-11-02 | -$294.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | -$166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $122.00K 10-Q · filed 2012-08-09 | -$80.00K derived: sum of 3 quarters · filed 2013-03-08 | -$338.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $288.00K 10-Q · filed 2012-05-04 | $86.00K derived: sum of 2 quarters · filed 2013-03-08 | -$172.00K derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | -$202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$460.00K derived: sum of 2 quarters · filed 2013-03-08 | -$1.86M 10-K · filed 2013-03-08 | |
| 2010-09-30 | -$258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$1.66M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$1.41M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $2.70M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |